SAM #REQT-OMAS-PS-2026-00010

Sole Source Clinical Pharmacology Compendia Licenses for Medicare Hearings

The Department of Health and Human Services (HHS), through the Office of Mission Acquisition Solutions (OMAS), is planning a sole source procurement for Clinical Pharmacology Compendia Licenses for the Office of Medicare Hearings and Appeals (OMHA). - Government Buyer: - Department of Health and Human Services (HHS) - Office of Mission Acquisition Solutions (OMAS) - Office of Medicare Hearings and Appeals (OMHA) - OEM Highlight: - Elsevier Inc. is the sole source and manufacturer of the Clinical Pharmacology Compendia Licenses - Products/Services Requested: - 32 Clinical Pharmacology Compendia Licenses Subscription - Provides access to a comprehensive drug information database with over 50,000 medication products - Used for determining Medicare Part B anti-cancer drug coverage - Notable Requirements: - Sole source procurement; only Elsevier's solution is being considered - Licenses are critical for Medicare Part B anti-cancer drug therapy coverage determinations - Period of Performance: - 12-month base period with four 12-month option periods (potential total of 5 years)

Description

See attached. 

View original listing